{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T17:00:17Z","timestamp":1786467617081,"version":"build-2736575974"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Obes"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>This study investigated butyrylcholinesterase (BChE) activity and its genetic variants (\u2212116, A, and K) in Afro-Brazilian individuals living in two African-derived communities (quilombos) in southern Brazil. Parameters, including obesity, glucose, and lipid profile, were compared with those of Euro-Brazilian individuals from the same region. The study aimed to characterize population parameters and assess their influence on factors involved in metabolic syndrome, obesity, and type 2 diabetes mellitus (TDM2).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A total of 198 Afro-Brazilians and 114 Euro-Brazilians participated. BChE activity was measured using the Ellman method, and variants were genotyped by PCR-SSP. Statistical analyses included\n                      <jats:italic>t<\/jats:italic>\n                      -test or Mann\u2013Whitney, ANOVA, chi-square or Fisher\u2019s exact test, correlations, and age- and sex-adjusted regression models.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The mean BChE activity in the Quilombola population was 3.71\u2009U\/mL and was significantly higher in people with TDM2 and\/or obesity (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.016), and associated with triglycerides, total cholesterol, overweight, and male sex. A significant interaction between triglycerides and glycated hemoglobin was observed (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.016). BChE activity was higher in Quilombolas than in Euro-Brazilians, regardless of metabolic status, suggesting ethnic influence. BCHE gene variants (A, \u2212116, and K) showed frequencies similar to other populations. Although enzymatic activity varied among haplotypes, differences were not statistically significant. These results highlight the relevance of clinical and ethnic factors in interpreting BChE activity.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study revealed higher BChE activity and TDM2 prevalence in Afro-Brazilian populations compared to Euro-Brazilians, and these differences correlate with non-genetic factors. The BCHE genetic variants investigated showed no robust associations after correction for multiple testing, suggesting that their effects on metabolic traits may be subtle and context-dependent. This is the first study to quantify BChE activity in Afro-Brazilian Quilombola populations and the second in Black individuals in Brazil, highlighting the importance of considering genetic and ethnic factors in metabolic risk assessment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41366-026-02095-2","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T23:19:29Z","timestamp":1778627969000},"page":"1751-1760","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Butyrylcholinesterase as a potential biomarker of metabolic imbalances in Afro-descendant populations"],"prefix":"10.1038","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-8409-6801","authenticated-orcid":false,"given":"Denise Raquel","family":"de Moura Bones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0470-8571","authenticated-orcid":false,"given":"Marcia Machado","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natali F\u00e1tima","family":"Veigand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iriel","family":"Araceli Joerin-Luque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie Mary","family":"Sukow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah Elisabeth","family":"Cupertino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscila Ianzen","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hellen Karoline","family":"de Oliveira Nunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aymee Fernanda","family":"Gros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor Dobis","family":"Barros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8797-112X","authenticated-orcid":false,"given":"Joana Gehlen","family":"Tessaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luana Leonardo","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabela Dall Oglio","family":"Bucco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Let\u00edcia Boslooper","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Cec\u00edlia Guimar\u00e3es","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thalia Roberta","family":"de Moraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selma \u00c1rabe","family":"Andrietta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas Farias","family":"de Cristo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa dos","family":"Santos Ribeiro Zanette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana In\u00eas","family":"de Paula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0514-9421","authenticated-orcid":false,"given":"Aline Borsato","family":"Hauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudemira Vieira Gusm\u00e3o","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciane Viater","family":"Turek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lupe Furtado","family":"Alle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Lehtonen Rodrigues Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcia Holsbach","family":"Beltrame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"2095_CR1","doi-asserted-by":"publisher","unstructured":"Sridhar GR, Gumpeny L. Emerging significance of butyrylcholinesterase. World J Exp Med. 2024;14. https:\/\/doi.org\/10.5493\/wjem.v14.i1.87202.","DOI":"10.5493\/wjem.v14.i1.87202"},{"key":"2095_CR2","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1002\/med.21745","volume":"41","author":"S Xing","year":"2021","unstructured":"Xing S, Li Q, Xiong B, Chen Y, Feng F, Liu W, et al. Structure and therapeutic uses of butyrylcholinesterase: application in detoxification, Alzheimer\u2019s disease, and fat metabolism. Med Res Rev. 2021;41:858\u2013901. https:\/\/doi.org\/10.1002\/med.21745.","journal-title":"Med Res Rev"},{"key":"2095_CR3","doi-asserted-by":"publisher","first-page":"399","DOI":"10.36472\/msd.v11i12.1233","volume":"11","author":"E Mustaqe","year":"2024","unstructured":"Mustaqe E, Liolis E, Bekou E, Tchabashvili L, Tasios K, Antzoulas A, et al. Costs of inflammatory markers worldwide and the use of butyrylcholinesterase (BChE). Med Sci Discov. 2024;11:399\u2013401. https:\/\/doi.org\/10.36472\/msd.v11i12.1233.","journal-title":"Med Sci Discov"},{"key":"2095_CR4","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1373\/clinchem.2005.065052","volume":"52","author":"A Valle","year":"2006","unstructured":"Valle A, O\u2019Connor DT, Taylor P, Zhu G, Montgomery GW, Slagboom PE, et al. Butyrylcholinesterase: association with the metabolic syndrome and identification of 2 gene loci affecting activity. Clin Chem. 2006;52:1014\u201320. https:\/\/doi.org\/10.1373\/clinchem.2005.065052.","journal-title":"Clin Chem"},{"key":"2095_CR5","doi-asserted-by":"publisher","unstructured":"Alc\u00e2ntara VM, Oliveira LC, R\u00e9a RR, Suplicy HL, Chautard-Freire-Maia EA. Butyrylcholinesterase activity and metabolic syndrome in obese patients. Clin Chem Lab Med. 2005;43. https:\/\/doi.org\/10.1515\/CCLM.2005.048.","DOI":"10.1515\/CCLM.2005.048"},{"key":"2095_CR6","doi-asserted-by":"publisher","first-page":"3086","DOI":"10.1210\/en.2016-1166","volume":"157","author":"VP Chen","year":"2016","unstructured":"Chen VP, Gao Y, Geng L, Stout MB, Jensen MD, Brimijoin S. Butyrylcholinesterase deficiency promotes adipose tissue growth and hepatic lipid accumulation in male mice on high-fat diet. Endocrinology. 2016;157:3086\u201395. https:\/\/doi.org\/10.1210\/en.2016-1166.","journal-title":"Endocrinology"},{"key":"2095_CR7","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.2169\/internalmedicine.55.6637","volume":"55","author":"E Oda","year":"2016","unstructured":"Oda E. Serum cholinesterase (butyrylcholinesterase) may play a role in body weight homeostasis via the inactivation of ghrelin. Intern Med. 2016;55:1245. https:\/\/doi.org\/10.2169\/internalmedicine.55.6637.","journal-title":"Intern Med"},{"key":"2095_CR8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1476-511X-4-18","volume":"4","author":"G Sridhar","year":"2005","unstructured":"Sridhar G, Nirmala G, Apparao A, Madhavi A, Sreelatha S, Rani JS, et al. Serum butyrylcholinesterase in type 2 diabetes mellitus: a biochemical and bioinformatics approach. Lipids Health Dis. 2005;4:18. https:\/\/doi.org\/10.1186\/1476-511X-4-18.","journal-title":"Lipids Health Dis"},{"key":"2095_CR9","doi-asserted-by":"publisher","first-page":"4504","DOI":"10.1093\/hmg\/ddr375","volume":"20","author":"B Benyamin","year":"2011","unstructured":"Benyamin B, Middelberg RP, Lind PA, Valle AM, Gordon S, Nyholt DR, et al. GWAS of butyrylcholinesterase activity identifies four novel loci, independent effects within BCHE and secondary associations with metabolic risk factors. Hum Mol Genet. 2011;20:4504\u201314. https:\/\/doi.org\/10.1093\/hmg\/ddr375.","journal-title":"Hum Mol Genet"},{"key":"2095_CR10","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1073\/pnas.86.3.953","volume":"86","author":"MC McGuire","year":"1989","unstructured":"McGuire MC, Nogueira CP, Bartels CF, Lightstone H, Hajra A, Van der Spek AF, et al. Identification of the structural mutation responsible for the dibucaine-resistant (atypical) variant form of human serum cholinesterase. Proc Natl Acad Sci USA. 1989;86:953\u20137. https:\/\/doi.org\/10.1073\/pnas.86.3.953.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2095_CR11","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1097\/FPC.0b013e3282f06646","volume":"17","author":"MR G\u00e4tke","year":"2007","unstructured":"G\u00e4tke MR, Bundgaard JR, Viby-Mogensen J. Two novel mutations in the BCHE gene in patients with prolonged duration of action of mivacurium or succinylcholine during anaesthesia. Pharmacogenet Genomics. 2007;17:995\u20139. https:\/\/doi.org\/10.1097\/FPC.0b013e3282f06646.","journal-title":"Pharmacogenet Genomics"},{"key":"2095_CR12","doi-asserted-by":"publisher","first-page":"e13714","DOI":"10.1097\/MD.0000000000013714","volume":"97","author":"C Zhang","year":"2018","unstructured":"Zhang C, Cao H, Wan ZG, Wang J. Prolonged neuromuscular block associated with cholinesterase deficiency. Medicine. 2018;97:e13714. https:\/\/doi.org\/10.1097\/MD.0000000000013714.","journal-title":"Medicine"},{"key":"2095_CR13","doi-asserted-by":"publisher","unstructured":"Davis J, Vincent A, Shanmugam G. Pseudocholinesterase deficiency and patient perspectives. Int J Anesthetic Anesthesiol. 2021. https:\/\/doi.org\/10.23937\/2377-4630\/1410124.","DOI":"10.23937\/2377-4630\/1410124"},{"key":"2095_CR14","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.pharmthera.2014.11.011","volume":"148","author":"O Lockridge","year":"2015","unstructured":"Lockridge O. Review of human butyrylcholinesterase structure, function, genetic variants, history of use in the clinic, and potential therapeutic uses. Pharm Ther. 2015;148:34\u201346. https:\/\/doi.org\/10.1016\/j.pharmthera.2014.11.011.","journal-title":"Pharm Ther"},{"key":"2095_CR15","unstructured":"FDA. Anectine \u00ae (Succinylcholine Chloride Injection, USP). 2018. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2010\/008453s027lbl.pdf."},{"key":"2095_CR16","doi-asserted-by":"publisher","first-page":"405","DOI":"10.2147\/PGPM.S263741","volume":"13","author":"G Zhu","year":"2020","unstructured":"Zhu G, Dawson E, Huskey A, Gordon RJ, Del Tredici AL. Genetic testing for BCHE variants identifies patients at risk of prolonged neuromuscular blockade in response to succinylcholine. Pharmgenomics Pers Med. 2020;13:405\u201314. https:\/\/doi.org\/10.2147\/PGPM.S263741.","journal-title":"Pharmgenomics Pers Med"},{"key":"2095_CR17","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.cbi.2008.04.019","volume":"175","author":"L Furtado-Alle","year":"2008","unstructured":"Furtado-Alle L, Andrade FA, Nunes K, Mikami LR, Souza RLR, Chautard-Freire-Maia EA. Association of variants of the -116 site of the butyrylcholinesterase BCHE gene to enzyme activity and body mass index. Chem Biol Interact. 2008;175:115\u20138. https:\/\/doi.org\/10.1016\/j.cbi.2008.04.019.","journal-title":"Chem Biol Interact"},{"key":"2095_CR18","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/FPC.0b013e3282f5107e","volume":"18","author":"LR Mikami","year":"2008","unstructured":"Mikami LR, Wieseler S, Souza RLR, Schopfer LM, Nachon F, Lockridge O, et al. Five new naturally occurring mutations of the BCHE gene and frequencies of 12 butyrylcholinesterase alleles in a Brazilian population. Pharmacogenet Genomics. 2008;18:213\u20138. https:\/\/doi.org\/10.1097\/FPC.0b013e3282f5107e.","journal-title":"Pharmacogenet Genomics"},{"key":"2095_CR19","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.mehy.2010.08.008","volume":"75","author":"GR Sridhar","year":"2010","unstructured":"Sridhar GR, Rao AA, Srinivas K, Nirmala G, Lakshmi G, Suryanarayna D, et al. Butyrylcholinesterase in metabolic syndrome. Med Hypotheses. 2010;75:648\u201351. https:\/\/doi.org\/10.1016\/j.mehy.2010.08.008.","journal-title":"Med Hypotheses"},{"key":"2095_CR20","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1590\/1678-4685-GMB-2016-0123","volume":"40","author":"JLV Oliveira","year":"2017","unstructured":"Oliveira JLV, Tureck W, Santos LF, Saliba CS, Schenknecht D, Scaraboto, et al. Effect of BCHE single nucleotide polymorphisms on lipid metabolism markers in women. Genet Mol Biol. 2017;40:408\u201314. https:\/\/doi.org\/10.1590\/1678-4685-GMB-2016-0123.","journal-title":"Genet Mol Biol"},{"key":"2095_CR21","doi-asserted-by":"publisher","first-page":"141","DOI":"10.18468\/pracs.2018v11n2.p141-153","volume":"11","author":"WS Matos","year":"2019","unstructured":"Matos WS, Eugenio BG. Comunidades quilombolas: elementos conceituais para sua compreens\u00e3o. PRACS Revista Eletr\u00f4nica de Humanidades do Curso de Ci\u00eancias Sociais da UNIFAP. 2019;11:141. https:\/\/doi.org\/10.18468\/pracs.2018v11n2.p141-153.","journal-title":"PRACS Revista Eletr\u00f4nica de Humanidades do Curso de Ci\u00eancias Sociais da UNIFAP"},{"key":"2095_CR22","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1590\/S1516-18462011005000033","volume":"13","author":"DA Freitas","year":"2011","unstructured":"Freitas DA, Caballero AD, Marques AS, Hern\u00e1ndez CIV, Antunes SLNO. Sa\u00fade e comunidades quilombolas: uma revis\u00e3o da literatura. Rev 28 Cefac. 2011;13:937\u201343. https:\/\/doi.org\/10.1590\/S1516-18462011005000033.","journal-title":"Rev 28 Cefac"},{"key":"2095_CR23","doi-asserted-by":"publisher","first-page":"e10291","DOI":"10.55905\/revconv.17n.9-057","volume":"17","author":"CL Carlota","year":"2024","unstructured":"Carlota CL, Peixoto MMCL, Oliviera MJ. Ra\u00edzes fortes, desafios maiores: uma revis\u00e3o de literatura sobre o cotidiano nas comunidades quilombolas. Contribuciones A Las Ciencias Sociales. 2024;17:e10291. https:\/\/doi.org\/10.55905\/revconv.17n.9-057.","journal-title":"Contribuciones A Las Ciencias Sociales"},{"key":"2095_CR24","unstructured":"Petruccelli, JL. A cor determinada. 2000. https:\/\/files.cercomp.ufg.br\/weby\/up\/1154\/o\/A_cor_denominada_Petruccelli.pdf?1599238938."},{"key":"2095_CR25","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1590\/S1415-47572014000400003","volume":"37","author":"LV Turek","year":"2014","unstructured":"Turek LV, Leite N, Souza RLR, Lima JK, Milano GE, Timossi LS, et al. Gender-dependent association of HSD11B1 single nucleotide polymorphisms with glucose and HDL-C levels. Genet Mol Biol. 2014;37:490\u20135. https:\/\/doi.org\/10.1590\/S1415-47572014000400003.","journal-title":"Genet Mol Biol"},{"key":"2095_CR26","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1093\/clinchem\/19.11.1309","volume":"19","author":"AA Dietz","year":"1973","unstructured":"Dietz AA, Rubinstein HM, Lubrano T. Colorimetric determination of serum cholinesterase and its genetic variants by the propionylthiocholine-dithiobis (nitrobenzoic acid) procedure. Clin Chem. 1973;19:1309\u201313.","journal-title":"Clin Chem"},{"key":"2095_CR27","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1093\/clinchem\/24.10.1762","volume":"24","author":"RT Evans","year":"1978","unstructured":"Evans RT, Wroe J. Is serum cholinesterase activity a predictor of succinyl choline sensitivity? An assessment of four methods. Clin Chem. 1978;24:1762\u20136.","journal-title":"Clin Chem"},{"key":"2095_CR28","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","volume":"7","author":"GL Ellman","year":"1961","unstructured":"Ellman GL, Courtney KD, Andres V, Jr. Feather-Stone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 1961;7:88\u201395.","journal-title":"Biochem Pharmacol"},{"key":"2095_CR29","doi-asserted-by":"publisher","unstructured":"Little S. Amplification-refractory mutation system (ARMS) analysis of point mutations. Curr Protoc Hum Genet. 2001;7:Chapter 9. https:\/\/doi.org\/10.1002\/0471142905.hg0908s07","DOI":"10.1002\/0471142905.hg0908s07"},{"key":"2095_CR30","doi-asserted-by":"publisher","DOI":"10.29327\/540652.1-1","author":"M Rodacki","year":"2021","unstructured":"Rodacki M, Bezerra MGT, Gabbay MAL, Montenegro Junior RM, Bertoluci MC. Classifica\u00e7\u00e3o do diabetes. Dir da Soc Brasileira de Diab. 2021. https:\/\/doi.org\/10.29327\/540652.1-1.","journal-title":"Dir da Soc Brasileira de Diab"},{"key":"2095_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-022-12753-5","volume":"22","author":"LT de Siqueira Valadares","year":"2022","unstructured":"de Siqueira Valadares LT, de Souza LSB, Salgado J\u00fanior VA, de Freitas Bonomo L, de Macedo LR, Silva M. Prevalence of metabolic syndrome in Brazilian adults in the last 10 years: a systematic review and meta-analysis. BMC Public Health. 2022;22:327. https:\/\/doi.org\/10.1186\/s12889-022-12753-5.","journal-title":"BMC Public Health"},{"key":"2095_CR32","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1136\/jech.2011.142976g.2","volume":"66","author":"F Clark","year":"2012","unstructured":"Clark F, Jackson J, Carlson M, Chou CP. Stability of biomarkers in plasma frozen at various temperatures for several years: implications for prospective epidemiological studies. J Epidemiol Community Health. 2012;66:782\u201390. https:\/\/doi.org\/10.1136\/jech.2011.142976g.2.","journal-title":"J Epidemiol Community Health"},{"key":"2095_CR33","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1177\/000456328402100504","volume":"21","author":"JM Turner","year":"1984","unstructured":"Turner JM, Hall RA, Whittaker M, Kricka LJ. Effects of storage and repeated freezing and thawing on plasma cholinesterase activity. Ann Clin Biochem. 1984;21:363\u20135. https:\/\/doi.org\/10.1177\/000456328402100504.","journal-title":"Ann Clin Biochem"},{"key":"2095_CR34","unstructured":"Brazilian Ministry of Health. Vigitel Brazil 2023: surveillance of risk and protective factors for chronic diseases by telephone survey: estimates of frequency and sociodemographic distribution of risk and protective factors for chronic diseases in the capitals of the 26 Brazilian states and the Federal District in 2023. 2023. \/https:\/\/bvsms.saude.gov.br\/bvs\/publicacoes\/vigitel_brasil_2023.pdf."},{"key":"2095_CR35","doi-asserted-by":"publisher","first-page":"6184","DOI":"10.3390\/ijms15046184","volume":"15","author":"U Jung","year":"2014","unstructured":"Jung U, Choi MS. Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int J Mol Sci. 2014;15:6184\u2013223. https:\/\/doi.org\/10.3390\/ijms15046184.","journal-title":"Int J Mol Sci"},{"key":"2095_CR36","doi-asserted-by":"publisher","unstructured":"Mukherjee S, Kundu R, Vidakovi\u0107 M. Editorial: Metaflammation in obesity and diabetes. Front Endocrinol. 2025;15. https:\/\/doi.org\/10.3389\/fendo.2024.1540999.","DOI":"10.3389\/fendo.2024.1540999"},{"key":"2095_CR37","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3892\/mmr.2024.13219","volume":"29","author":"FN Varra","year":"2024","unstructured":"Varra FN, Varras M, Varra VK, Theodosis-Nobelos P. Molecular and pathophysiological relationship between obesity and chronic inflammation in the manifestation of metabolic dysfunctions and their inflammation\u2011mediating treatment options (Review). Mol Med Rep. 2024;29:95. https:\/\/doi.org\/10.3892\/mmr.2024.13219.","journal-title":"Mol Med Rep"},{"key":"2095_CR38","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.amepre.2018.07.014","volume":"55","author":"RA Nianogo","year":"2018","unstructured":"Nianogo RA, Arah OA. Impact of public health interventions on obesity and type 2 diabetes prevention: a simulation study. Am J Prev Med. 2018;55:795\u2013802. https:\/\/doi.org\/10.1016\/j.amepre.2018.07.014.","journal-title":"Am J Prev Med"},{"key":"2095_CR39","doi-asserted-by":"publisher","first-page":"316","DOI":"10.7322\/jhgd.152182","volume":"28","author":"LVDA Sousa","year":"2018","unstructured":"Sousa LVDA, Maciel EDS, Quaresma FRP, Abreu ACG, Paiva LDS, Fonseca FLA, et al. Quality of life and metabolic syndrome in Brazilian quilombola communities: a cross-sectional study. J Hum Growth Dev. 2018;28:316\u201328. https:\/\/doi.org\/10.7322\/jhgd.152182.","journal-title":"J Hum Growth Dev"},{"key":"2095_CR40","unstructured":"RStudio Team. RStudio: integrated development for R. Boston, MA: RStudio, PBC; 2020. http:\/\/www.rstudio.com\/."},{"key":"2095_CR41","doi-asserted-by":"publisher","unstructured":"Furtado-Alle L, Tureck LV, de Oliveira CS, Hortega JVM, Souza RLR. Butyrylcholinesterase and lipid metabolism: possible dual role in metabolic disorders. 2023;383:110680. https:\/\/doi.org\/10.1016\/j.cbi.2023.110680.","DOI":"10.1016\/j.cbi.2023.110680"},{"key":"2095_CR42","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.clinbiochem.2005.04.008","volume":"38","author":"EW Randell","year":"2005","unstructured":"Randell EW, Mathews MS, Zhang H, Seraj JS, Sun G. Relationship between serum butyrylcholinesterase and the metabolic syndrome. Clin Biochem. 2005;38:799\u2013805. https:\/\/doi.org\/10.1016\/j.clinbiochem.2005.04.008.","journal-title":"Clin Biochem"},{"key":"2095_CR43","doi-asserted-by":"publisher","first-page":"377","DOI":"10.2459\/JCM.0B013E3283627700","volume":"15","author":"NG Vallianou","year":"2014","unstructured":"Vallianou NG, Evangelopoulos AA, Bountziouka V, Bonou MS, Katsagoni C, Vogiatzakis ED, et al. Association of butyrylcholinesterase with cardiometabolic risk factors among apparently healthy adults. J Cardiovasc Med. 2014;15:377\u201383. https:\/\/doi.org\/10.2459\/JCM.0B013E3283627700.","journal-title":"J Cardiovasc Med"},{"key":"2095_CR44","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1590\/1678-4685-GMB-2016-0123","volume":"40","author":"J Oliveira","year":"2017","unstructured":"Oliveira J, Tureck LV, Santos W, Saliba LF, Schenknecht CS, Scaraboto D, et al. Effect of BCHE single nucleotide polymorphisms on lipid metabolism markers in women. Genet Mol Biol. 2017;40:408\u201314. https:\/\/doi.org\/10.1590\/1678-4685-GMB-2016-0123.","journal-title":"Genet Mol Biol"},{"key":"2095_CR45","doi-asserted-by":"publisher","unstructured":"Mansour MF, Chan CWJ, Laforest S, Veilleux A, Tchernof A. Sex differences in body fat distribution. In: Symonds M, editor. Adipose tissue biology. Cham: Springer; 2017. pp. 257\u2013300. https:\/\/doi.org\/10.1007\/978-3-319-52031-5_8.","DOI":"10.1007\/978-3-319-52031-5_8"},{"key":"2095_CR46","doi-asserted-by":"publisher","unstructured":"Tchernof A, Brochu D, Maltais-Payette I, Mansour MF, Marchand GB, Carreau AM, et al. Androgens and the regulation of adiposity and body fat distribution in humans. Compr Physiol. 2018:1253\u201390. https:\/\/doi.org\/10.1002\/cphy.c170009.","DOI":"10.1002\/cphy.c170009"},{"key":"2095_CR47","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1007\/s11845-022-03087-7","volume":"192","author":"JN da Concei\u00e7\u00e3o Filho","year":"2023","unstructured":"da Concei\u00e7\u00e3o Filho JN, Dos Santos IC, Gon\u00e7alves DPJ, Ferreira JRD, Godoy ALPC. Black and non-black population: investigation of the difference in butyrylcholinesterase activity in a healthy population in Salvador, Bahia. Ir J Med Sci. 2023;192:1311\u20139. https:\/\/doi.org\/10.1007\/s11845-022-03087-7.","journal-title":"Ir J Med Sci"},{"key":"2095_CR48","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1021\/acs.chemrestox.6b00228","volume":"29","author":"O Lockridge","year":"2016","unstructured":"Lockridge O, Norgren RB Jr, Johnson RC, Blake TA. Naturally occurring genetic variants of human acetylcholinesterase and butyrylcholinesterase and their potential impact on the risk of toxicity from cholinesterase inhibitors. Chem Res Toxicol. 2016;29:1381\u201392. https:\/\/doi.org\/10.1021\/acs.chemrestox.6b00228.","journal-title":"Chem Res Toxicol"},{"key":"2095_CR49","doi-asserted-by":"publisher","first-page":"546","DOI":"10.7705\/biomedica.v26i4","volume":"26","author":"J Carmona-Fonseca","year":"2006","unstructured":"Carmona-Fonseca J. Correlaci\u00f3n y conversi\u00f3n entre valores de colinesterasa eritrocitaria medida con las t\u00e9cnicas de Michel y EQM. Biomedica. 2006;26:546. https:\/\/doi.org\/10.7705\/biomedica.v26i4.","journal-title":"Biomedica"},{"key":"2095_CR50","doi-asserted-by":"publisher","first-page":"e101552","DOI":"10.1371\/journal.pone.0101552","volume":"9","author":"H Delacour","year":"2014","unstructured":"Delacour H, Lushchekina S, Mabboux I, Bousquet A, Ceppa F, Schopfer LM, et al. Characterization of a novel BCHE \u201cSilent\u201d Allele: point mutation (p.Val204Asp) causes loss of activity and prolonged apnea with suxamethonium. PLoS ONE. 2014;9:e101552. https:\/\/doi.org\/10.1371\/journal.pone.0101552.","journal-title":"PLoS ONE"},{"key":"2095_CR51","first-page":"113","volume":"21","author":"O Lockridge","year":"2000","unstructured":"Lockridge O, Masson P. Pesticides and susceptible populations: people with butyrylcholinesterase genetic variants may be at risk. Neurotoxicology. 2000;21:113\u201326.","journal-title":"Neurotoxicology"},{"key":"2095_CR52","doi-asserted-by":"publisher","first-page":"736","DOI":"10.2298\/VSP160303101Z","volume":"74","author":"M Zlatkovic","year":"2017","unstructured":"Zlatkovic M, Krstic N, Subota V, Boskovic B, Vucinic S. Determination of reference values of acetyl and butyryl cholinesterase activities in Serbian healthy population. Vojnosanit Pregl. 2017;74:736\u201341. https:\/\/doi.org\/10.2298\/VSP160303101Z.","journal-title":"Vojnosanit Pregl"},{"key":"2095_CR53","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/ajpa.10413","volume":"126","author":"RLR Souza","year":"2005","unstructured":"Souza RLR, Fadel-Picheth C, Allebrandt KV, Furtado L, Chautard-Freire-Maia EA. Possible influence of BCHE locus of butyrylcholinesterase on stature and body mass index. Am J Phys Anthropol. 2005;126:329\u201334. https:\/\/doi.org\/10.1002\/ajpa.10413.","journal-title":"Am J Phys Anthropol"},{"key":"2095_CR54","doi-asserted-by":"publisher","unstructured":"Johansen A, Nielsen EMD, Andersen G, Hamid YH, Jensen DP, Glmer C, et al. Large-scale studies of the functional K variant of the butyrylcholinesterase gene in relation to Type 2 diabetes and insulin secretion. Diabetologia. 2004;47. https:\/\/doi.org\/10.1007\/s00125-004-1459-7.","DOI":"10.1007\/s00125-004-1459-7"},{"key":"2095_CR55","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1007\/s11033-009-9666-4","volume":"37","author":"A Vaisi-Raygani","year":"2010","unstructured":"Vaisi-Raygani A, Rahimi Z, Tavilani H, Pourmotabbed T. Butyrylcholinesterase K variant and the APOE-epsilon 4 allele work in synergy to increase the risk of coronary artery disease especially in diabetic patients. Mol Biol Rep. 2010;37:2083\u201391. https:\/\/doi.org\/10.1007\/s11033-009-9666-4.","journal-title":"Mol Biol Rep"},{"key":"2095_CR56","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1017\/S1461145705005468","volume":"9","author":"S K\u00f5ks","year":"2006","unstructured":"K\u00f5ks S, Nikopensius T, Koido K, Maron E, Altm\u00e4e S, Heinaste E, et al. Analysis of SNP profiles in patients with major depressive disorder. Int J Neuropsychopharmacol. 2006;9:167\u201374. https:\/\/doi.org\/10.1017\/S1461145705005468.","journal-title":"Int J Neuropsychopharmacol"},{"key":"2095_CR57","first-page":"33","volume":"25","author":"S K\u00f5ks","year":"2000","unstructured":"K\u00f5ks S, M\u00e4nnist\u00f6 PT, Bourin M, Shlik J, Vasar V, Vasar E. Cholecystokinin-induced anxiety in rats: relevance of pre-experimental stress and seasonal variations. J Psychiatry Neurosci. 2000;25:33\u201342.","journal-title":"J Psychiatry Neurosci"},{"key":"2095_CR58","doi-asserted-by":"publisher","first-page":"8284","DOI":"10.1523\/JNEUROSCI.0976-17.2017","volume":"37","author":"JJ Tuulari","year":"2017","unstructured":"Tuulari JJ, Tuominen L, de Boer FE, Hirvonen J, Helin S, Nuutila P, et al. Feeding releases endogenous opioids in humans. J Neurosci. 2017;37:8284\u201391. https:\/\/doi.org\/10.1523\/JNEUROSCI.0976-17.2017.","journal-title":"J Neurosci"}],"container-title":["International Journal of Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02095-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02095-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02095-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T16:24:08Z","timestamp":1786465448000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02095-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":58,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["2095"],"URL":"https:\/\/doi.org\/10.1038\/s41366-026-02095-2","relation":{},"ISSN":["0307-0565","1476-5497"],"issn-type":[{"value":"0307-0565","type":"print"},{"value":"1476-5497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"assertion":[{"value":"30 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All participants provided written informed consent prior to enrollment. The study received ethical approval from the Research Ethics Committee of the Federal University of Paran\u00e1 (CEP\/SD 4.639.630\/CAAE 42761521.9.0000.0102). All methods were performed in accordance with the relevant guidelines and regulations, and all procedures followed established ethical and methodological standards.","order":2,"name":"Ethics","label":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}